TECON BIOLOGY Co.LTD (TECON BIOLOGY CO LTD) Aktie

TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the provision of animal health care, feed, pig breeding, agricultural product processing and trade, and financial services in China and internationally. The company offers pigs, poultry, dairy cows, ruminants, aquatic feed products, as well as premixes and additives. The Pharmaceutical division researches and develops livestock and poultry disease vaccine products; and cottonseed meal and oils, cotton hull, and short plush, as well as engages in pig genetics and breeding; commercial pig breeding and fattening; feeding technology research and development; pig slaughtering and processing; meat processing; and cold chain distribution and sales. It is also involved in the purchase and sale of agricultural and sideline products; drying, storage, and logistics of agricultural crops; agricultural machinery provision; processing of grain storage equipment; import and export of goods and technology; railway freight forwarding; road freight transport; container transport services provision; production, processing, sales, and agency activity of agricultural materials, etc. The company was formerly known as Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd. and changed its name to Tecon Biology Co.Ltd in June 2016. Tecon Biology Co.Ltd was founded in 1993 and is headquartered in Urumqi, China.